Published in Blood Weekly, January 13th, 2005
The drug R115777 (Zarnestra) (tipifarnib) produced responses that ranged from complete responses to improvement in blood counts in about one-third of 82 patients treated at 7 different hospitals in the United States, Canada, and Europe, said the study's lead investigator, Razelle Kurzrock, MD, a professor in the department of experimental therapeutics...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.